Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
Earnings Data
Report Date
May 07, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.07Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Q1 2026
Earnings Call Date:Feb 17, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
Balanced/Neutral — The call highlighted multiple operational and clinical achievements (accelerated programs, regulatory clearance, strong early clinical outcomes, product adoption, and meaningful fiscal 2026 revenue guidance of at least $10.5M). However, these positives are offset by near-term financial headwinds including a year-over-year revenue decline driven by the absence of prior license revenue, a drop in gross margin, a swing to a net loss, and a substantial reduction in cash on hand with funding only assured through fiscal 2026 unless milestones are met. The company shows promising commercial and development momentum but faces tangible liquidity and margin pressures that moderate the overall outlook.Company Guidance
Fiscal 2026 Revenue Guidance
Company projects fiscal 2026 sales of at least $10.5M, representing a minimum 17% increase versus fiscal 2025.
Sequential Revenue Growth
Product revenue of $2.9M in Q1 FY2026 increased 5.5% sequentially from $2.7M in the prior quarter.
1RF Brain Ablation Adoption
Number of ablations performed in Q1 FY2026 was nearly half of all ablations since launch, indicating rapid penetration and adoption of the 1RF brain ablation system; positive clinical anecdotes shared (e.g., professional pianist resuming career). Registry planned with first patient enrollment target by end of Q3.
Trigeminal Nerve System Clinical Success
1RF trigeminal nerve ablation received FDA 510(k) clearance (Aug 2025). Limited commercial launch: 9 patients treated across 3 centers in 2026 with all reported pain free to date; first two patients at University Hospitals Cleveland reported pain relief. Limited launch expected to complete by 2026; in diligence discussions with strategics for potential licensing.
Accelerated Drug Delivery Program
Drug delivery program accelerated; devices expected to be available for investigational clinical studies or animals in Q3 FY2026 (~6 months ahead of prior schedule). Advisory board of oncology experts being organized and active discussions with pharma/biotech partners underway.
Back Pain Programs Progress
14‑gauge needle program: long-term animal study to start next month in preparation for first human implant; basivertebral nerve ablation program: multiple advisory board meetings held, product requirements validated, and strategic diligence ongoing.
Cost Discipline in SG&A
Selling, general & administrative expense decreased 7.7% year-over-year to $1.9M (from $2.0M), indicating some operating cost control.
No Debt and Strategic Board Addition
Company reported no outstanding debt as of 12/31/2025 and appointed Jason Mills (formerly EVP Strategy, Penumbra) to the board to support business development and strategic efforts.
NMTC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NMTC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 17, 2026 | $0.81 | $0.68 | -16.48% |
Dec 17, 2025 | $0.71 | $0.67 | -5.38% |
Aug 14, 2025 | $0.86 | $0.83 | -3.38% |
May 13, 2025 | $0.62 | $0.64 | +3.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does NeuroOne Medical Technologies (NMTC) report earnings?
NeuroOne Medical Technologies (NMTC) is schdueled to report earning on May 07, 2026, Before Open (Confirmed).
What is NeuroOne Medical Technologies (NMTC) earnings time?
NeuroOne Medical Technologies (NMTC) earnings time is at May 07, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NMTC EPS forecast?
Currently, no data Available